We used inhibitors to investigate the role of specific BCR-associated kinases in Ag presentation by CLL cells and were able to demonstrate a substantial role for SYK and PI3Kδ, but not BTK, in Ag presentation from soluble anti-IgM. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.